Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04321408Recruiting

OP2C : Prialt® Observatory in Clinical Practice

Role: collaborator

NCT05290727Not ApplicableCompleted

Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort

Role: collaborator

NCT04001244Completed

Translational Research in Pelvic Pain

Role: collaborator

NCT00728715Not ApplicableCompleted

Efficacy of Budesonide-Formoterol in Bronchiectasis

Role: collaborator

All 4 trials loaded